151 related articles for article (PubMed ID: 11342040)
1. Isolation of chymase complexed with physiological inhibitor similar to secretory leukocyte protease inhibitor (SLPI) from hamster cheek pouch tissues.
Takao K; Takai S; Ishihara T; Mita S; Miyazaki M
Biochim Biophys Acta; 2001 Feb; 1545(1-2):146-52. PubMed ID: 11342040
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
Pemberton AD; Huntley JF; Miller HR
Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch.
Takai S; Shiota N; Yamamoto D; Okunishi H; Miyazaki M
Life Sci; 1996; 58(7):591-7. PubMed ID: 8632712
[TBL] [Abstract][Full Text] [Related]
4. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
Walter M; Plotnick M; Schechter NM
Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
[TBL] [Abstract][Full Text] [Related]
6. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
9. The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis.
Murata E; Sharmin S; Shiota H; Shiota M; Yano M; Kido H
Curr Eye Res; 2003 May; 26(5):271-6. PubMed ID: 12854054
[TBL] [Abstract][Full Text] [Related]
10. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
11. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
[TBL] [Abstract][Full Text] [Related]
12. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
Ohlsson K; Bjartell A; Lilja H
J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
14. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role.
King AE; Critchley HO; Kelly RW
Mol Hum Reprod; 2000 Feb; 6(2):191-6. PubMed ID: 10655462
[TBL] [Abstract][Full Text] [Related]
15. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
[TBL] [Abstract][Full Text] [Related]
16. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma.
Fath MA; Wu X; Hileman RE; Linhardt RJ; Kashem MA; Nelson RM; Wright CD; Abraham WM
J Biol Chem; 1998 May; 273(22):13563-9. PubMed ID: 9593692
[TBL] [Abstract][Full Text] [Related]
17. Purification of a serine-proteinase inhibitor from human articular cartilage. Identity with the acid-stable proteinase inhibitor of mucous secretions.
Böhm B; Deutzmann R; Burkhardt H
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):269-73. PubMed ID: 2001242
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction.
Forteza RM; Ahmed A; Lee T; Abraham WM
Pulm Pharmacol Ther; 2001; 14(2):107-10. PubMed ID: 11273791
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a novel Kazal-type serine proteinase inhibitor of neutrophil elastase from sheep lung.
Mistry R; Snashall PD; Totty N; Briskin S; Guz A; Tetley TD
Biochim Biophys Acta; 1997 Sep; 1342(1):51-61. PubMed ID: 9366270
[TBL] [Abstract][Full Text] [Related]
20. Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli.
Masuda K; Kamimura T; Kanesaki M; Ishii K; Imaizumi A; Sugiyama T; Suzuki Y; Ohtsuka E
Protein Eng; 1996 Jan; 9(1):101-6. PubMed ID: 9053897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
